Peer-to-Peer Podcast CME Information

Target Audience
This educational activity has been planned in accordance with the need to provide cardiologists and other health care professionals managing patients with atrial fibrillation with important information on stroke prevention among patients with AF.

Expert Faculty

N. A. Mark Estes, MD (Chairperson) Director New England Cardiac Arrhythmia Center Cardiac Electrophysiology and Pacemaker Laboratory Tufts Medical Center Professor of Medicine Tufts University School of Medicine Boston, Massachusetts

Pierre Fayad, MD Reynolds Centennial Professor and Chairman Department of Neurological Sciences College of Medicine Medical Director of Neurology University of Nebraska Medical Center Omaha, Nebraska

Peter R. Kowey, MD Chief Division of Cardiovasuclar Diseases Lankenau Hospital Main Line Health System Professor of Medicine and Clinical Pharmacology Jefferson Medical College Thomas Jefferson University Philadelphia, Pennsylvania

Educational Activity Objective
Upon completion of this activity, the participants should be able to
• Utilize available stroke risk stratification schemes to further identify risk profiles among patients within your clinical practice

Accreditation Statement
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement
The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release/Expiration Dates
This activity is eligible for CME credit from February 2010 to February 28, 2011.

Resolution of Conflicts of Interest
In accordance with the ACCME Standards for Commercial Support of CME, The University of Nebraska Medical Center, Center for Continuing Medical Education and The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Disclosure
It is the policy of The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, and staff involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation have identified and resolved any and all conflicts of interest prior to the release of this activity.

Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, or other members at the University of Nebraska Medical Center, Center for Continuing Medical Education who control content have no relevant financial relationships to disclose.

Faculty Disclosures
The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:

N. A. Mark Estes III, MD, FACC, FAHA, FHRS, has received honoraria and other financial support from Boston Scientific.

Pierre Fayad, MD, has received grant and research support from AGA and NINDS. He has served as a consultant for Boehringer Ingelheim and sanofi-aventis.

Peter R. Kowey, MD, FACC, FACP, FACCP, FHRS, has served as a consultant for ARYx Therapeutics, Astellas Pharma Inc, AstraZeneca, Boehringer Ingelheim, Cardiome, Daiichi Sankyo, GlaxoSmithKline, Johnson & Johnson, Portola Pharmaceuticals, Inc, sanofi-aventis, and Wyeth. He is a stock shareholder for CardioNet and has received honoraria from GlaxoSmithKline and sanofi-aventis.

Disclaimer
The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education, The France Foundation, and Boehringer Ingelheim assume no liability for the information herein.